20 June 2013
Keywords: gsk, drops, japanese, partner, zantac, uk, drug
Article | 28 April 2008
UK drug giant GlaxoSmithKline has terminated its co-marketing agreement for the now off patent antiulcer drug Zantac (ranitidine) in Japan ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 April 2008
19 June 2013
© 2013 thepharmaletter.com